Most tumors contain regions of low oxygen concentration where cancer therapies based on the action of reactive oxygen species are ineffective. Now, American scientists have developed a hybrid nanomaterial that releases a free-radical-generating prodrug inside tumor cells upon thermal activation. As they report in the journal Angewandte Chemie, the free radicals destroy the cell components even in oxygen-depleted conditions, causing apoptosis. Delivery, release, and action of the hybrid material can be precisely controlled.
Many well-established cancer treatment schemes are based on the generation of reactive oxygen species (ROS), which induce apoptosis for the tumor cells. However, this mechanism only works in the presence of oxygen, and hypoxic (oxygen-depleted) regions in the tumor tissue often survive the ROS-based treatment. Therefore, Younan Xia at the Georgia Institute of Technology and Emory University, Atlanta, USA, and his team have developed a strategy to deliver and release a radical-generating prodrug that, upon activation, damages cells by a ROS-type radical mechanism, but without the need for oxygen.
The authors explained that they had to turn to the field of polymerization chemistry to find a compound that produces enough radicals. There, the azo compound AIPH is a well-known polymerization initiator. In medicinal applications, it generates free alkyl radicals that cause DNA damage and lipid and protein peroxidation in cells even under hypoxic conditions. However, the AIPH must be safely delivered to the cells in the tissue. Thus, the scientists used nanocages, the cavities of which were filled with lauric acid, a so-called phase-change material (PCM) that can serve as a carrier for AIPH. Once inside the target tissue, irradiation by a near-infrared laser heats up the nanocages, causing the PCM to melt and triggering the release and decomposition of AIPH.
Image Credit: Triche National Cancer Institute
News This Week
A pea-sized device used to seal tiny but potentially deadly holes in the hearts of premature infants has been approved by U.S. regulators, making it one of the smallest complex medical devices ever invented [...]
Scientists have discovered that squamous cell skin cancers do not require increased glucose to power their development and growth, contrary to a long-held belief about cancer metabolism. The findings could bring about a better [...]
Nanotechnology may well be one of the most talked about industries of the last few years. Predicted to value US$173.95 billion globally by 2025, this fast-moving sector is already delivering major sustainability, health and [...]
Catalysts are chemical matchmakers: They bring other chemicals close together, increasing the chance that they’ll react with each other and produce something people want, like fuel or fertilizer. Since some of the best catalyst [...]
In a first-of-its-kind study, researchers used an ingenious experimental setup and high-energy X-ray beams to observe a high-temperature, high-pressure chemical reaction to establish how the formation of two varied nanoscale crystalline structures in the [...]